(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2(Date:9/4/2008)...Enroll 750 Women at More Than 100 Sites in the U.S...Rx Pharmaceuticals, a,privately-held biopharmaceut...ization of compounds to treat endocrine, metabolic...t it has initiated a second,Phase 3 clinical trial...,estrogen-free oral therapy in development for the...
(Date:9/4/2008)...ival Data for Ipilimumab to be Presented, PRINCET...x, Inc.,(Nasdaq: MEDX ) announced today that nine...onal anti-CTLA-4 antibody, in melanoma are schedul...Congress of the European Society,for Medical Oncol...ckholm.,Many of the following abstracts will inclu...
(Date:9/4/2008)...atient Identification for Targeted Therapies ...ment HUNTINGTON BEACH, Calif., and AMSTERDAM, N...ld leader in molecular cancer diagnostics,today a...ostic test that,allows physicians to quantitativel...ogen receptor (ER), progesterone receptor (PR) and...
(Date:9/3/2008)...ept. 4 /Xinhua--,Pharmaceut...day announced,that it has enrolled the first subje...evaluating Bronchitol in cystic fibrosis sufferers...pitals across North,America, Argentina and Germany...seeks approval to market Bronchitol for cystic fib...
Breaking Medicine Technology:QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Insomnia in parents can result in sleep problems suicidal behavior among their offspring 21644 1Insomnia in parents can result in sleep problems suicidal behavior among their offspring 21644 2Poor sleep linked to suicidal behavior among children and adolescents with depressive episodes 21641 1Poor sleep linked to suicidal behavior among children and adolescents with depressive episodes 21641 2Poor sleep linked to suicidal behavior among children and adolescents with depressive episodes 21641 3Cell Therapeutics Inc Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor 5947 1Cell Therapeutics Inc Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor 5947 2U S District Court Finds Arthrex Guilty of Willfully Infringing Smith 26 Nephew Endoscopy Patent 21638 1U S District Court Finds Arthrex Guilty of Willfully Infringing Smith 26 Nephew Endoscopy Patent 21638 2U S District Court Finds Arthrex Guilty of Willfully Infringing Smith 26 Nephew Endoscopy Patent 21638 3...20, 2007 - Australian,biotechnology company Avexa ...s from its Phase IIb trial for apricitabine (ATC)....tase inhibitor,(NRTI) being developed for the trea...tant HIV., The Phase IIb trial compared the effect...nts with drug-resistant HIV with,the effectiveness...
...ontinued Health,(REACH) , - Registry 1-Year Result... Registry 1-year,results paper published today in ...AMA) show that outpatients with,atherothrombosis h...diovascular illness, especially if more than one v...h event rates that accrued,almost linearly over ti...
Other Medicine Technology:Avexa Reports Positive Phase IIb Result 2Avexa Reports Positive Phase IIb Result 3Avexa Reports Positive Phase IIb Result 4REACH Registry Demonstrates That Multiple Arterial Disease,Locations Sharply Increase the Risk of Major CV Events in,Outpatients With Atherothrombosis 2REACH Registry Demonstrates That Multiple Arterial Disease,Locations Sharply Increase the Risk of Major CV Events in,Outpatients With Atherothrombosis 3REACH Registry Demonstrates That Multiple Arterial Disease,Locations Sharply Increase the Risk of Major CV Events in,Outpatients With Atherothrombosis 4Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details
Each solid state catheter kit below is supplied with adapter cable(s) for Polygraf ID and a Manometric Calibrator.
Air-Charged Catheters make motility testing simpler than ever before. Disposable Latitude catheters set up in seconds and protect against cross-contamination. And with every sensor circumferential, A
Replacement Stopper for LATITUDE® Air-Charged Catheter
Medicine Products: